BPI France launches InnoBio 2
BPI France, alongside Sanofi, Boehringer Ingelheim, Takeda, Ipsen and Servier, have launched InnoBio 2, setting a target of €200-250m and aiming for a first close in September.
More on Funds
Horizon to hold a close for $200m fund
Emerging Europe Growth Fund III was launched in June 2016 with a target of $150m
Adams Street closes Global Fund 2018 on $824m
Adams Street held a first close on $125m in December 2017 and had raised $225m by April 2018
Omnes holds €72m interim close for Expansion III
GP plans to hold a final close in H1 2019, sets target at €120m and hard-cap at €150m
Kurma holds first close for Kurma Biofund III
LPs including Servier, BPI France and Idinvest commit to the biotech- and heath-focused fund
Latest News
Pantheon promotes two and names COO
Richards and Dunwoodie both held the role of investment team principals prior to the promotion
Adams Street closes Global Fund 2018 on $824m
Adams Street held a first close on $125m in December 2017 and had raised $225m by April 2018
Naxicap’s DCI bolts on Retis
DCI’s bolt-on of communications specialist Retis follows the acquisition of Lhexian last year
YFM exits Gill Marine
Exit delivers a 2x return on YFM Equity Partners' original £9m investment, made in September 2013